Lymphoma, T-Cell, Cutaneous - 27 Studies Found
Completed |
: Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2007-06-21 : Drug: LBH589 Other Name: panobinostat |
Completed |
: Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma : Cutaneous T-cell Lymphoma : 2007-11-05 :
|
Recruiting |
: A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma : Persistent or Recurrent Cutaneous T-Cell Lymphoma : 2013-03-28 : Drug: E7777 administered by intravenous (i.v.) infusion over 60 minutes (+/-10 minutes) on 5 consecutive |
Terminated |
: Everolimus in Treating Cutaneous T-cell Lymphoma : Cutaneous T-Cell Lymphoma : 2012-04-02 : Drug: Everolimus The study drug everolimus will be self-ad |
Withdrawn |
: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) : Cutaneous T-cell Lymphoma (CTCL) : 2013-04-24 : Drug: Sirolimus 0.1% Ointment Sirolimus 0.1% ointment will be applied topically to all affected areas of |
Recruiting |
: Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas :
: 2014-12-12 :
|
Completed |
: A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2008-08-29 : Drug: Enzastaurin 1125 mg loading dose then 500 mg, oral, daily, until disease progression |
Completed |
: Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study : Cutaneous T-Cell Lymphoma : 2008-10-22 : Drug: Tazarotene Topical 0.1 cream - apply to lesions on alternate days and at 2 week interval increase |
Recruiting |
: Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma : Cutaneous T-cell Lymphoma : 2014-02-11 :
|
Completed |
: Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) : Refractory Cutaneous T-cell Lymphoma : 2009-11-03 :
|